SNYDER CAPITAL MANAGEMENT L P - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 194 filers reported holding HAEMONETICS CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SNYDER CAPITAL MANAGEMENT L P ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2015$7,152,000
-77.2%
221,279
-70.9%
0.46%
-73.7%
Q2 2015$31,405,000
-31.6%
759,300
-25.7%
1.76%
-24.4%
Q1 2015$45,910,000
+6.5%
1,022,029
-11.3%
2.33%
+2.8%
Q4 2014$43,100,000
+7.8%
1,151,787
+0.6%
2.27%
+1.5%
Q3 2014$39,972,000
-12.7%
1,144,687
-11.8%
2.24%
+5.5%
Q2 2014$45,772,000
+14.9%
1,297,387
+6.1%
2.12%
+2.3%
Q1 2014$39,843,000
-27.0%
1,222,547
-5.6%
2.07%
-22.8%
Q4 2013$54,553,000
+8.6%
1,294,884
+2.8%
2.68%
+3.0%
Q3 2013$50,253,000
-2.8%
1,260,106
+0.8%
2.61%
-5.7%
Q2 2013$51,681,0001,249,8462.76%
Other shareholders
HAEMONETICS CORP shareholders Q2 2013
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders